跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 198 条关于
“Aβ oligomers”
全部
198
临床试验
30
药物
28
机构
1
资讯
139
去年
ProMIS Neurosciences to Present at Guggenheim Securities SMID Cap Biotech Conference
去年
Galimedix Advances Oral GAL-101 Therapy for Alzheimer's and Eye Diseases in Phase 1 Trial
去年
Galimedix Therapeutics Initiates Phase 2 Trial of GAL-101 Eye Drops for Dry AMD
4个月前
Risen Pharma Initiates Phase 2 Trial of RP902 for Alzheimer's Disease in China
去年
Galimedix Therapeutics Completes Phase 1 Trial of Oral Alzheimer's Drug GAL-101
去年
Alzheon's ALZ-801 Shows Promise in Reducing Phosphorylated Tau and Enhancing Memory in Early Alzheimer's Disease
去年
Acumen Pharmaceuticals Utilizes pTau217 Assay in Sabirnetug Phase 2 Alzheimer's Trial
去年
Cognition Therapeutics' CT1812 Shows Promise in Phase 2 Trials for Alzheimer's and Lewy Body Dementia
6个月前
Galimedix Achieves Phase 1 Milestone for Oral GAL-101 in Alzheimer's Disease Development
3年前
Advances in Alzheimer's Disease Treatment: A Focus on Disease-Modifying Therapies
第 1 页,共 14 页
上一页
下一页